Alpha 2.0
Login Register
» Articles » PMID: 27034564

Serendipitous Discovery of Peritoneal Mesothelioma

Overview
Journal Proc (Bayl Univ Med Cent)
Specialty General Medicine
Date 2016 Apr 2
PMID 27034564
Citations 4
Authors
Adam Jaster
Jason Wachsmann
Affiliations
Soon will be listed here.
Abstract

We present the case of a 64-year-old patient with a history of Birt-Hogg-Dube syndrome, polycystic kidney disease treated with renal transplantation in May 2013, and multiple types of skin cancers, including malignant melanoma. He presented for lymphoscintigraphy for sentinel lymph node identification of the melanoma. Subsequent biopsy of the right axillary sentinel lymph node yielded a diagnosis of epithelial type malignant mesothelioma without a known primary tumor. Follow-up positron emission tomography with 2-deoxy-2-(fluorine-18)fluoro-D-glucose integrated with computed tomography (F-18 FDG PET/CT) demonstrated several suspicious hypermetabolic abdominal masses that were later confirmed to be epithelial-type mesothelioma via percutaneous biopsy.

Citing Articles

Minimally Invasive Plasma Device Management of Multiple Benign Skin Cancers Associated with Rare Genodermatoses-Case Series and Review of the Therapeutic Methods.

Platkowska A, Slowinska M, Zalewska J, Swacha Z, Szumera-Cieckiewicz A, Wagrodzki M J Clin Med. 2024; 13(15).

PMID: 39124644 PMC: 11312861. DOI: 10.3390/jcm13154377.

Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.

Gupta S, Erickson L, Lohse C, Shen W, Pitel B, Knight S JAMA Netw Open. 2021; 4(11):e2132615.

PMID: 34767027 PMC: 8590170. DOI: 10.1001/jamanetworkopen.2021.32615.

Value of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy to treat malignant peritoneal mesothelioma.

Wang T, Li H, Ye B, Zhang D Am J Transl Res. 2021; 13(9):10712-10720.

PMID: 34650746 PMC: 8506998.

Melanoma in a patient with previously unrecognized Birt-Hogg-Dubé syndrome.

Nowsheen S, Hand J, Gibson L, El-Azhary R JAAD Case Rep. 2019; 5(11):947-952.

PMID: 31687461 PMC: 6820253. DOI: 10.1016/j.jdcr.2019.08.018.

References
1.
van Meerbeeck J, Scherpereel A, Surmont V, Baas P . Malignant pleural mesothelioma: the standard of care and challenges for future management. Crit Rev Oncol Hematol. 2010; 78(2):92-111. DOI: 10.1016/j.critrevonc.2010.04.004. View
2.
Cao Q, Lu M, Heath J, Hausner P, Alexander H, Dilsizian V . 18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma. Clin Nucl Med. 2012; 37(5):492-4. DOI: 10.1097/RLU.0b013e3182478bb5. View
3.
Domenech-Vilardell A, Rasiej M, Taub R, Ichise M . Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma. Q J Nucl Med Mol Imaging. 2014; 60(1):54-61. View
4.
Bridda A, Padoan I, Mencarelli R, Frego M . Peritoneal mesothelioma: a review. MedGenMed. 2007; 9(2):32. PMC: 1994863. View
5.
Ozguven S, Aras M, Dede F, Ones T, Turoglu H . Scrotal peritoneal mesothelioma on PET/CT. Clin Nucl Med. 2014; 39(12):1045-6. DOI: 10.1097/RLU.0000000000000590. View